Clincosm LogoSign in Get a demo

healthy participants

Showing 1 - 25 of 323
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Participants Trial in Istanbul (Evaluation of Viscoelastic and mechanical properties with MyotonPRO)

Completed
  • Healthy Participants
  • Evaluation of Viscoelastic and mechanical properties with MyotonPRO
  • İstanbul, Uskudar, Turkey
    University of Health Sciences
Sep 6, 2023

Alzheimer, Dementia, Healthy Participants Trial (Brain Health Education, Alzheimer Disease Education)

Not yet recruiting
  • Alzheimer Disease
  • +3 more
  • Brain Health Education
  • Alzheimer Disease Education
  • (no location specified)
Aug 30, 2023

Healthy Participants Trial in Aarhus (Structural only, Structural+Group MI)

Enrolling by invitation
  • Healthy Participants
  • Structural only
  • Structural+Group MI
  • Aarhus, Denmark
    Centre for Alcohol and Drug Research, Aarhus BSS, Aarhus Univers
Aug 31, 2023

Healthy Participants, Healthy Population Trial in Basel (Personalized Miamind Neurostimulator)

Not yet recruiting
  • Healthy Participants
  • Healthy Population
  • Personalized Miamind Neurostimulator
  • Basel, Basel-Stadt, Switzerland
    Universitätsspital Basel
Aug 24, 2023

Healthy Participants Trial in Lincoln (AB521)

Recruiting
  • Healthy Participants
  • Lincoln, Nebraska
    Celerion, Inc.
Aug 22, 2023

Healthy Participants Trial in New Haven (PF-06954522, Placebo)

Not yet recruiting
  • Healthy Participants
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Aug 15, 2023

Healthy Participants Trial in Brussels (Vepdegestrant, Carbamazepine)

Not yet recruiting
  • Healthy Participants
  • Brussels, Belgium
    Pfizer Clinical Research Unit - Brussels
Aug 15, 2023

Healthy Participants Trial in Villeurbanne (Immersive virtual reality task)

Not yet recruiting
  • Healthy Participants
  • Immersive virtual reality task
  • Villeurbanne, France
    Charpennes Geriatric Hospital, Lyon University Hospital
Aug 16, 2023

Healthy Participants Trial in Neuss (Semaglutide)

Not yet recruiting
  • Healthy Participants
  • Neuss, Germany
    Novo Nordisk Investigational Site
Aug 10, 2023

Healthy Participants Trial in Cypress, Miami, Las Vegas (Abatacept)

Not yet recruiting
  • Healthy Participants
  • Abatacept
  • Cypress, California
  • +2 more
Aug 1, 2023

Healthy Participants Trial in Glendale (AZD5055, Placebo)

Not yet recruiting
  • Healthy Participants
  • Glendale, California
    Research Site
Jul 13, 2023

Healthy Participants Trial in Brussel (Estraimod Immediate Release (IR), Etrasimod Mini Tab in water, Etrasimod Mini Tab in

Not yet recruiting
  • Healthy Participants
  • Estraimod Immediate Release (IR)
  • +4 more
  • Brussel, Belgium
    Brussels Clinical Research Unit
Jul 20, 2023

Healthy Participants Trial in Miami (Lu AG06474, Placebo)

Recruiting
  • Healthy Participants
  • Lu AG06474
  • Placebo
  • Miami, Florida
    Quotient
Jul 10, 2023

Aiming at Pre-Analytical Standardization of Whole Blood

Not yet recruiting
  • Healthy Participants
    • (no location specified)
    Jul 4, 2023

    Healthy Participants Trial in Ann Arbor (Functional magnetic resonance imaging (fMRI))

    Not yet recruiting
    • Healthy Participants
    • Functional magnetic resonance imaging (fMRI)
    • Ann Arbor, Michigan
      University of Michigan
    Jun 28, 2023

    Healthy Participants Trial in Bron (High-definition transcranial direct current (HD-tDCS), active condition, High-definition

    Not yet recruiting
    • Healthy Participants
    • High-definition transcranial direct current (HD-tDCS), active condition
    • High-definition transcranial direct current (HD-tDCS), placebo condition
    • Bron, France
      Centre Hospitalier le Vinatier
    Jun 30, 2023

    Healthy Participants Trial (BMS-986278, Itraconazole, Gemfibrozil)

    Not yet recruiting
    • Healthy Participants
    • (no location specified)
    Jun 27, 2023

    Healthy Participants Trial in Overland Park (Treatment A: Emraclidine 30mg IR tablets (reference), Treatment B: Emraclidine 30mg

    Not yet recruiting
    • Healthy Participants
    • Treatment A: Emraclidine 30mg IR tablets (reference)
    • +3 more
    • Overland Park, Kansas
      Overland Park, Kansas
    Jun 28, 2023

    Healthy Participants Trial in Tempe (Aficamten, Aficamten-matching Placebo, Moxifloxacin)

    Recruiting
    • Healthy Participants
    • Tempe, Arizona
      Celerion, Inc 2420
    Jun 27, 2023

    Healthy Participants Trial (Single dose of PF-07220060 as first Tablet Formulation, Single dose of PF-07220060 as second Tablet

    Not yet recruiting
    • Healthy Participants
    • Single dose of PF-07220060 as first Tablet Formulation
    • +3 more
    • (no location specified)
    Jun 20, 2023

    Healthy Participants Trial (PF-07293893, Placebo)

    Not yet recruiting
    • Healthy Participants
    • (no location specified)
    Jun 8, 2023

    Healthy Participants Trial (Afimetoran, Phenytoin, Midazolam)

    Not yet recruiting
    • Healthy Participants
    • (no location specified)
    Jun 5, 2023

    Healthy Participants Trial (PF-07853578, Placebo)

    Not yet recruiting
    • Healthy Participants
    • (no location specified)
    May 25, 2023

    Healthy Participants Trial (Combination [RSVpreF+BNTb162b2], Bivalent BNT162b2 (original/Omi BA.4/BA.5), RSVpreF)

    Not yet recruiting
    • Healthy Participants
    • Combination [RSVpreF+BNTb162b2]
    • +4 more
    • (no location specified)
    May 31, 2023

    Healthy Participants Trial in Tempe (CK-4021586, Placebo for CK-4021586)

    Recruiting
    • Healthy Participants
    • Tempe, Arizona
      Celerion
    May 17, 2023